What does APOTEEK VERLINDE do?

APOTEEK VERLINDE is a logistics company in Dentergem. Public Limited, started on 23 December 1991, 1 establishment.

What is the address of APOTEEK VERLINDE?

The registered office of APOTEEK VERLINDE is located at Wontergemstraat(Den) 30, 8720 Dentergem.

Is APOTEEK VERLINDE still active?

Yes. According to the CBE (30 October 2026) APOTEEK VERLINDE is active, legal situation “Normale toestand”, started on 23 December 1991.

Is APOTEEK VERLINDE registered on Peppol?

Yes, APOTEEK VERLINDE is registered on the Peppol network with ID 0208:0446155458.

What is the enterprise number of APOTEEK VERLINDE?

The enterprise number of APOTEEK VERLINDE is BE0446155458.

When was APOTEEK VERLINDE founded?

APOTEEK VERLINDE was founded on 23 December 1991.

Who are the directors of APOTEEK VERLINDE?

According to the 2024 annual accounts, the directors of APOTEEK VERLINDE are: LARSFIEN.

Is APOTEEK VERLINDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 1991; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did APOTEEK VERLINDE make in 2024?

APOTEEK VERLINDE posted a profit after taxes of € 133,203 in financial year 2024.

What is the revenue of APOTEEK VERLINDE?

As a small company, APOTEEK VERLINDE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 251,173.

How much does an employee at APOTEEK VERLINDE earn?

The average wage cost per full-time employee at APOTEEK VERLINDE was € 70,300 in 2023: staff costs of € 105,386 for 1.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTEEK VERLINDE have?

According to the 2024 annual accounts, APOTEEK VERLINDE has 0.9 full-time equivalents (FTE).

Does APOTEEK VERLINDE have a website?

Yes, APOTEEK VERLINDE has a website at apotheekverlinde.be.

APOTEEK VERLINDE (Public Limited) - Dentergem

Dossier APOTEEK VERLINDE, printed on 30 October 2026 from databakkes.be/en/0446155458/apoteek-verlinde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

APOTEEK VERLINDE from Dentergem, company number BE0446155458, closed financial year 2024 with a result of € 133,203 after tax. For that financial year APOTEEK VERLINDE recorded a gross margin of € 251,173 and equity of € 563,177. Compared with financial year 2023, the result moved from € 85,984 to € 133,203. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2025.

What it is worth Growing

€ 563,177

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 133,203

▲ 55% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 340,428

▲ 104% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 132,000 paid out

99 % of the profit went to the shareholders, mostly to LARSFIEN (100 % of the shares). That is where the money ends up.

People and assets in 2024

Full-time equivalents

0.9

▼ 0.6 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 76,741

▼ 27% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,572

▼ 32% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 65,938

▲ 7% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,107

▼ 30% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 151,556 Gross margin 2021: € 151,556 First fiscal year in the series	€ 187,863 Gross margin 2022: € 187,863 ▲ 24% vs 2021 (€ 151,556) Favourable step	€ 230,928 Gross margin 2023: € 230,928 ▲ 23% vs 2022 (€ 187,863) Favourable step	€ 251,173 Gross margin 2024: € 251,173 ▲ 9% vs 2023 (€ 230,928) Favourable step	▲ 9%
Profit after taxes	€ 53,936 Profit after taxes 2021: € 53,936 First fiscal year in the series	€ 51,163 Profit after taxes 2022: € 51,163 ▼ 5% vs 2021 (€ 53,936) Unfavourable step	€ 85,984 Profit after taxes 2023: € 85,984 ▲ 68% vs 2022 (€ 51,163) Favourable step	€ 133,203 Profit after taxes 2024: € 133,203 ▲ 55% vs 2023 (€ 85,984) Favourable step	▲ 55%
Equity	€ 560,727 Equity 2021: € 560,727 First fiscal year in the series	€ 561,490 Equity 2022: € 561,490 Unchanged (€ 560,727) Favourable step	€ 561,974 Equity 2023: € 561,974 Unchanged (€ 561,490) Favourable step	€ 563,177 Equity 2024: € 563,177 Unchanged (€ 561,974) Favourable step
Total debts	€ 195,525 Total debts 2021: € 195,525 First fiscal year in the series	€ 235,099 Total debts 2022: € 235,099 ▲ 20% vs 2021 (€ 195,525) Unfavourable step	€ 312,814 Total debts 2023: € 312,814 ▲ 33% vs 2022 (€ 235,099) Unfavourable step	€ 352,627 Total debts 2024: € 352,627 ▲ 13% vs 2023 (€ 312,814) Unfavourable step	▲ 13%
Cash	€ 154,640 Cash 2021: € 154,640 First fiscal year in the series	€ 206,111 Cash 2022: € 206,111 ▲ 33% vs 2021 (€ 154,640) Favourable step	€ 166,753 Cash 2023: € 166,753 ▼ 19% vs 2022 (€ 206,111) Unfavourable step	€ 340,428 Cash 2024: € 340,428 ▲ 104% vs 2023 (€ 166,753) Favourable step	▲ 104%
Land & buildings	€ 318,148 Land & buildings 2021: € 318,148 First fiscal year in the series	€ 306,560 Land & buildings 2022: € 306,560 ▼ 4% vs 2021 (€ 318,148) Unchanged	€ 300,448 Land & buildings 2023: € 300,448 ▼ 2% vs 2022 (€ 306,560) Unchanged	€ 284,611 Land & buildings 2024: € 284,611 ▼ 5% vs 2023 (€ 300,448) Unchanged	▼ 5%
Retained profit	€ 490,708 Retained profit 2021: € 490,708 First fiscal year in the series	€ 491,471 Retained profit 2022: € 491,471 Unchanged (€ 490,708) Favourable step	€ 491,955 Retained profit 2023: € 491,955 Unchanged (€ 491,471) Favourable step	€ 493,158 Retained profit 2024: € 493,158 Unchanged (€ 491,955) Favourable step
Dividend	€ 53,850 Dividend 2021: € 53,850 First fiscal year in the series	€ 50,400 Dividend 2022: € 50,400 ▼ 6% vs 2021 (€ 53,850) Unchanged	€ 85,500 Dividend 2023: € 85,500 ▲ 70% vs 2022 (€ 50,400) Unchanged	€ 132,000 Dividend 2024: € 132,000 ▲ 54% vs 2023 (€ 85,500) Unchanged	▲ 54%
Bank debt	€ 40,352 Bank debt 2021: € 40,352 First fiscal year in the series	€ 12,244 Bank debt 2022: € 12,244 ▼ 70% vs 2021 (€ 40,352) Favourable step	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 12,244) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 756,252 Balance sheet total 2021: € 756,252 First fiscal year in the series	€ 796,590 Balance sheet total 2022: € 796,590 ▲ 5% vs 2021 (€ 756,252) Unchanged	€ 874,788 Balance sheet total 2023: € 874,788 ▲ 10% vs 2022 (€ 796,590) Unchanged	€ 915,804 Balance sheet total 2024: € 915,804 ▲ 5% vs 2023 (€ 874,788) Unchanged	▲ 5%
Employees (FTE)	1 Employees (FTE) 2021: 1 First fiscal year in the series	1.4 Employees (FTE) 2022: 1.4 ▲ 0.4 vs 2021 (1) Unchanged	1.5 Employees (FTE) 2023: 1.5 ▲ 0.1 vs 2022 (1.4) Unchanged	0.9 Employees (FTE) 2024: 0.9 ▼ 0.6 vs 2023 (1.5) Unchanged	▼ 0.6

Key figures of APOTEEK VERLINDE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to APOTEEK VERLINDE?

What happened at APOTEEK VERLINDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2025 LARSFIEN stepped down as director. NBB
Jun 5, 2025 New annual accounts for financial year 2024: profit of € 133,203 (▲ 55% vs 2023). Source: NBB ↗
2019 LARSFIEN became a director. NBB
Jan 28, 1992 New establishment in Dentergem. KBO
Dec 23, 1991 Start of the company according to the CBE. KBO

In short

From € 53,936 profit in 2021 to € 133,203 profit in 2024.

Paid € 6,948 in corporate taxes since 2021.

Best year ever: 2024, with € 133,203 profit.

On average € 154,000 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

LARSFIEN 100%

The stake of LARSFIEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTEEK VERLINDE

The shares are held by LARSFIEN (100%).

Directors

According to the 2024 annual accounts

LARSFIEN

Director · represented by Verlinde ANN

since 2019 · until 2025

Shareholders

LARSFIEN

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Wontergemstraat(Den) 30

8720 Dentergem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

LARSFIEN same network

€ 154,367 gross margin · 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekverlinde.be

Technologies

AWS S3BootstrapChart.jsCloudflare CDNDiviElementorFont AwesomeGoogle FontsOwl CarouselPHPSwiperWPMLWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja

Languages EN

Features

Webshop Blog Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0446.155.458

VAT number

BE 0446.155.458

Registered office

Wontergemstraat(Den) 30, 8720 Dentergem

Names & denominations

APOTEEK VERLINDE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

23 December 1991

Peppol

Active · Active since 6 May 2025

Contact

apotheekverlinde.be

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTEEK VERLINDE

Financials

What happened to APOTEEK VERLINDE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions